Author:
Kobayashi Miwako,Farrar Jennifer L.,Gierke Ryan,Britton Amadea,Childs Lana,Leidner Andrew J.,Campos-Outcalt Doug,Morgan Rebecca L.,Long Sarah S.,Talbot H. Keipp,Poehling Katherine A.,Pilishvili Tamara
Publisher
Centers for Disease Control MMWR Office
Subject
Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology
Reference36 articles.
1. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).;CDC;MMWR Morb Mortal Wkly Rep,2010
2. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).;CDC;MMWR Morb Mortal Wkly Rep,2012
3. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).;Tomczyk;MMWR Morb Mortal Wkly Rep,2014
4. The efficacy and effectiveness of pneumococcal vaccines against pneumococcal pneumonia among adults: a systematic review and meta-analysis.;Childs;Open Forum Infect Dis,2021
5. Systematic review and meta-analysis of pneumococcal vaccine effectiveness against invasive pneumococcal disease among adults.;Farrar;Open Forum Infect Dis,2021
Cited by
225 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献